Purchase Order 36C26123P0366

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA-VHA) awarded a $298,647.72 delivery order contract to United Therapeutics Corporation under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The contract description references TYVASO, which is a proprietary treprostinil inhalation solution used to treat pulmonary arterial hypertension. United Therapeutics will provide TYVASO to the VA-VHA from its place of performance in...

The Department of Veterans Affairs Veterans Health Administration awarded a $85,327.92 firm fixed price delivery order against the United Therapeutics Corporation's Pharmaceuticals and Drugs schedule (FSS-61-IB) to provide TYVASO for Veterans Integrated Service Network 20. Performance will take place in Silver Spring, Maryland over a six-month period concluding on March 31, 2024. No subcontractors or set aside designations were specified. This order supports the VA's mission to provide quality...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $14,693.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to United Therapeutics Corporation for one kit of treprostinil (Tyvaso) 0.6mg/ml solution for inhalation, refill. Performance will occur in Silver Spring, Maryland by March 8, 2024. The contract utilizes the GSA Schedule for pharmaceuticals and drugs with firm fixed pricing and no...

United Therapeutics Corporation has been awarded a $15,649.11 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of TYVASO 64 MCG ORAL INH KIT to Bartlett, Tennessee, with performance required by March 16, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB for the purpose of...

This is a $75,656.34 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for a 6-month supply of Tyvaso (treprostinil) 0.6mg/mL inhalation solution refill kits. This delivery order is placed against United Therapeutics' $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for the supply of its...

This is a $16,031.60 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for the drug TYVASO 64 MCG KIT, which is used to treat pulmonary arterial hypertension. The delivery order was placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics also holds two...

This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $14,693.62 award is for the supply of the TYVASO 0.6 REFILL KIT, a medication used to treat pulmonary arterial hypertension. The contract was placed against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and...

United Therapeutics Corporation has been awarded a $109,543.77 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order has a completion date of September 30, 2023 and was awarded on March 21, 2023 to provide TYVASO, with no set-aside designation used. Place of performance will be in Bartlett, Tennessee. TYVASO will support the VA's mission...

United Therapeutics Corporation has been awarded a $14,221.32 delivery order against the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract to provide TYVASO 0.6MG/ML to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order has a completion date of April 28, 2023 and was awarded on April 2, 2023. No set-aside designation was used for this award. Performance will take place...

This firm fixed price delivery order for $16,031.60 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to United Therapeutics Corporation. The order is for TYVASO 64 MCG KIT and has a completion date of March 8, 2024. It was placed against United Therapeutics' pre-competed Pharmaceuticals and Drugs schedule contract with the General Services Administration, which has no set-aside designation. United Therapeutics will deliver the...